Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial)
Publication year
2018Source
American Journal of Cardiology, 122, 11, (2018), pp. 1896-1901ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Cardiology
Journal title
American Journal of Cardiology
Volume
vol. 122
Issue
iss. 11
Page start
p. 1896
Page end
p. 1901
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 16: Vascular damage RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227030]
- Electronic publications [108485]
- Faculty of Medical Sciences [86563]
- Open Access publications [77646]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.